350 related articles for article (PubMed ID: 35372003)
21. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
[TBL] [Abstract][Full Text] [Related]
22. NUT Carcinoma in a Patient with Unusually Long Survival and False Negative FISH Results.
McLean-Holden AC; Moore SA; Gagan J; French CA; Sher D; Truelson JM; Bishop JA
Head Neck Pathol; 2021 Jun; 15(2):698-703. PubMed ID: 32918711
[TBL] [Abstract][Full Text] [Related]
23. A recurrent novel
Diolaiti D; Dela Cruz FS; Gundem G; Bouvier N; Boulad M; Zhang Y; Chou AJ; Dunkel IJ; Sanghvi R; Shah M; Geiger H; Rahman S; Felice V; Wrzeszczynski KO; Darnell RB; Antonescu CR; French CA; Papaemmanuil E; Kung AL; Shukla N
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30552129
[No Abstract] [Full Text] [Related]
24. Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.
Fekkar A; Emprou C; Lefebvre C; Ferretti G; Stephanov O; Pissaloux D; Mc Leer A; Toffart AC; Rousseaux S; Khochbin S; Lantuejoul S; Valmary-Degano S
Lung Cancer; 2021 Aug; 158():55-59. PubMed ID: 34119933
[TBL] [Abstract][Full Text] [Related]
25. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
26. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract][Full Text] [Related]
27. Case report of a pan-cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3-NUT variant: Challenges in cytomorphologic presentation.
Hwang J; Marinelli L; Chormanski D; Rose H; Williams G; Adams T; Van Dellen M
Diagn Cytopathol; 2023 Jul; 51(7):E209-E213. PubMed ID: 37021735
[TBL] [Abstract][Full Text] [Related]
28. NUT Carcinoma-An Underdiagnosed Malignancy.
Lauer UM; Hinterleitner M; Horger M; Ohnesorge PV; Zender L
Front Oncol; 2022; 12():914031. PubMed ID: 35957893
[TBL] [Abstract][Full Text] [Related]
29. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract][Full Text] [Related]
30. NUT midline carcinoma.
French CA
Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
[TBL] [Abstract][Full Text] [Related]
31. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
32. Midline carcinoma of children and young adults with NUT rearrangement.
French CA; Kutok JL; Faquin WC; Toretsky JA; Antonescu CR; Griffin CA; Nose V; Vargas SO; Moschovi M; Tzortzatou-Stathopoulou F; Miyoshi I; Perez-Atayde AR; Aster JC; Fletcher JA
J Clin Oncol; 2004 Oct; 22(20):4135-9. PubMed ID: 15483023
[TBL] [Abstract][Full Text] [Related]
33. Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing.
Ardalan B; Azqueta J; Luo J; French C
Front Oncol; 2023; 13():1304457. PubMed ID: 38322288
[TBL] [Abstract][Full Text] [Related]
34.
Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194
[TBL] [Abstract][Full Text] [Related]
35. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
[TBL] [Abstract][Full Text] [Related]
36. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
Christensen DJ; Tuluc M
J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
[TBL] [Abstract][Full Text] [Related]
37. NUT carcinoma - An aggressive thoracic tumor.
Ribeiro JA; Sousa J; Jesus F; Almeida É; Costa JF; Reis M; Gomes RM
Am J Med Sci; 2023 Jul; 366(1):64-70. PubMed ID: 37100347
[TBL] [Abstract][Full Text] [Related]
38. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.
Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H
Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466
[TBL] [Abstract][Full Text] [Related]
39. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.
Ziai J; French CA; Zambrano E
Head Neck Pathol; 2010 Jun; 4(2):163-8. PubMed ID: 20352379
[TBL] [Abstract][Full Text] [Related]
40. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
